Delivery Order SPE2DB20D3304-SPE2DB25FW8T4
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $3,076.79 to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of NovoLog 100 Unit/mL vials (10 mL). This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The product will be performed at the contractor's Conshohocken, Pennsylvania facility, with an ultimate completion date of July 31, 2025. No...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,749.33 to AmerisourceBergen Drug Corp for the supply of NovoLog 100 Unit/mL vials (10 mL) on July 24, 2025, with an ultimate completion date of July 25, 2025. This firm fixed price delivery order was competitively awarded without set-aside provisions. The contract calls for performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. This delivery order is a child contract under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for NovoLog 100 Unit/mL vials (10 mL) with a ceiling value of $2,824.50 under a firm fixed price contract. The award was made on August 12, 2025, with an ultimate completion date of August 13, 2025, and represents a non-competitive set-aside delivery order. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for NovoLog 100 Unit/mL vials (10mL) with a ceiling value of $1,608.84. This competitively awarded, firm fixed-price delivery order was issued on August 1, 2025, with an ultimate completion date of August 4, 2025. The product will be delivered to the contractor's location in Conshohocken, Pennsylvania. This award represents a child contract under AmerisourceBergen's larger pharmaceutical supply agreement with...
- The Defense Logistics Agency awarded a $6,102.42 delivery order to AmerisourceBergen Drug Corp for NovoLog 100 Unit/mL vials (10mL) on July 30, 2025, with a completion date of July 31, 2025. This is a firm fixed price, non-set-aside contract to be performed at the company's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which...
- The Defense Logistics Agency awarded a delivery order valued at $2,890.32 to AmerisourceBergen Drug Corp for the supply of NovoLog 100 Unit/mL vials (10mL units). This contract, awarded on August 8, 2025, with an ultimate completion date of August 11, 2025, represents a firm fixed-price delivery order with no set-aside designation. The pharmaceutical product will be delivered to AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order is a child contract...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $2,592.90 for NovoLog 100 Unit/mL vials (10 mL) on July 28, 2025, with completion scheduled for July 29, 2025. This firm fixed price, non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.99 million and extending through December 2026. The product will be delivered to...
- The Defense Logistics Agency awarded a delivery order valued at $1,944.90 to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of NovoLog 100 Unit/mL vials (10 mL units). This is a firm fixed price, competitive delivery order with no set-aside designation, reflecting open competition among qualified pharmaceutical vendors. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of July 21, 2025....
- The Defense Logistics Agency awarded a $2,726.60 delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for NovoLog 100 Unit/mL vials (10 mL) with a completion date of August 4, 2025. This firm fixed price delivery order, which represents a non-set-aside competitive award, will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract falls under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of NovoLog 100 Unit/mL vials (10 mL) at a ceiling value of $11,722.08. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was competitively procured. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 8, 2025. This delivery order is a...
- SPE2DB20D3304Indefinite Delivery Contract
- SPE2DB20D3304-SPE2DB25FW8T4Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,204.22 to AmerisourceBergen Drug Corp for NovoLog 100 Unit/mL vials (10 mL) under a firm fixed price contract. This is a non-set-aside award issued on August 25, 2025, with an ultimate completion date of August 26, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive global pharmaceutical support vehicle running through December 2026. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. This delivery order for NovoLog insulin supports DLA's medical supply chain operations, which provide pharmaceutical and medical commodities to the Defense Health Agency, U.S. Coast Guard, and other government healthcare entities. The company's competitive federal contract portfolio demonstrates its capability to fulfill diverse medical supply requirements, ranging from specialty medications to vaccines and medical devices across multiple therapeutic domains. The firm fixed price structure and rapid completion timeline reflect typical delivery order operations under the broader pharmaceutical prime vendor framework.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.2k | 8/25/25 |